000 01329nam##2200337za#4500
0019.534150
003CaOODSP
00520200401015543
007ta
008150406|2000||||xxc|||||     f|0| 0 eng|d
020 |a0-660-61377-8
040 |aCaOODSP|beng
041 |aeng
041 |afre
043 |an-cn---
0861 |aBT31-4/64-2000
1101 |aCanada. |bTreasury Board.
24510|aPatented Medicine Prices Review Board Canada
260 |aOttawa - Ontario : |bTreasury Board of Canada Secretariat |c2000.
300 |aEnglish text, 34p. : |bgraphs, tables ; |c28 cm.
4901 |aPerformance report for the period ending March 31, 2000
546 |aBilingual
563 |aSoftcover
590 |a01-06|b2001-02-09
69007|aBudgets|2gcpds
69007|aFinancial management|2gcpds
69007|aProductivity|2gcpds
7760#|tConseil d'examen du prix des médicaments brevetés Canada, rapport sur le rendement pour la période se terminant le 31 mars 2000 |w(CaOODSP)9.600341
7760#|tPatented Medicine Prices Review Board Canada, performance report for the period ending March 31, 2000 |w(CaOODSP)9.569100
792 |tConseil d'examen du prix des médicaments brevetés Canada |w(CaOODSP)9.534151
830#0|aPerformance report for the period ending March 31, 2000.|w(CaOODSP)9.508978